A new formulation of the COMIRNATY booster "12 years of age and older, Ready
to use (Original/Omicron BA.1 Cap and Package, Multi-dose vial)" was approved
on DD/MM/YY with procedure X/0000.Additional website content relevant to this
new formulation will be available on DD/MM/YY.

COMIRNATY Original/Omicron BA.1 15/15 micrograms/per dose for dispersion
for injection, for 12 years of age and older, Ready to use (Original/Omicron BA.1
Cap and Package, Multi-dose vial)
PP-CMR-GLB-0188

This site is intended for Healthcare Professionals in Iraq.

The page you’re trying to reach is unavailable, or it may no longer exist.  To find what you’re looking for, please use any of the links above.
For more information ​​​​​​​

Medical Information
Visit: https://www.pmi-covid.com/en-afme/covid-19-mrna-vaccine-bnt162


The Pfizer-BioNTech COVID-19 Vaccine, which is based on
BioNTech proprietary mRNA technology, was developed
by both BioNTech and Pfizer.

This site is intended for Healthcare Professionals in  Lebanon. The products discussed in the site may have different product labeling in different countries. The information provided is for educational purposes only. 

​​​​​© 2022 Pfizer Inc. All rights reserved. February 2022. PP-CVV-GLB-0216

This site is intended for Healthcare Professionals in  Iraq. The products discussed in the site may have different product labeling in different countries. The information provided is for educational purposes only.